Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Imerys    NK   FR0000120859

IMERYS

(NK)
  Report  
Real-time Quote. Real-time Tradegate - 06/27 09:35:36 am
46.18 EUR   +0.74%
06/26IMERYS : - Update of the EMTN programme
AQ
06/13IMERYS : presents its 2019-2022 strategic plan at its Capital Markets Day
AQ
05/20IMERYS : Ex-dividend day for final dividend
FA
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
06/21/2019 06/24/2019 06/25/2019 06/26/2019 06/27/2019 Date
45.94(c) 45.06(c) 45.52(c) 45.84(c) 46.24 Last
891 364 227 173 342 694 132 491 35 235 Volume
-0.43% -1.92% +1.02% +0.70% +0.87% Change
More quotes
Financials (EUR)
Sales 2019 4 601 M
EBIT 2019 545 M
Net income 2019 328 M
Debt 2019 1 282 M
Yield 2019 4,72%
Sales 2020 4 698 M
EBIT 2020 587 M
Net income 2020 352 M
Debt 2020 1 164 M
Yield 2020 5,02%
P/E ratio 2019 9,98
P/E ratio 2020 10,34
EV / Sales2019 1,07x
EV / Sales2020 1,02x
Capitalization 3 644 M
More Financials
Company
As a world leader in mineral specialties for the industry, Imerys offers high-added-value business solutions for a wide range of sectors, from process industries to consumer goods or construction products. The group actively mobilizes its knowledge of applications, technological expertise and... 
Sector
Diversified Chemicals
Calendar
07/25 | 12:00pmEarnings Release
More about the company
Surperformance© ratings of Imerys
Trading Rating : Investor Rating :
More Ratings
Latest news on IMERYS
06/26IMERYS : - Update of the EMTN programme
AQ
06/13IMERYS : presents its 2019-2022 strategic plan at its Capital Markets Day
AQ
05/20IMERYS : Ex-dividend day for final dividend
FA
05/06IMERYS : first quarter 2019 results
PU
04/30IMERYS SA : quaterly earnings release
03/21IMERYS : - Availability conditiond of the 2018 Registration Document
AQ
03/20IMERYS : Availability conditiond of the 2018 Registration Document
PU
03/13IMERYS : California jury awards $29 million to woman with cancer who used J&J ta..
RE
02/14IMERYS : announces solid performance for full year 2018
AQ
02/14GLOBAL MARKETS LIVE : Google, Airbus, Volkswagen, Cisco…
More news
Analyst Recommendations on IMERYS
More recommendations
Stock Trading Strategies
IMERYS - 01/25
Hesitation should subside in favor of volatility
BUY
More Stock Trading Analysis
Sector news : Diversified Chemicals
06/26BRENNTAG : Shares in Germany's Brenntag drop on dual-use chemicals sale to Syria
RE
06/26BASF : German prosecutors haven't decided whether to investigate Brenntag after ..
RE
06/19Barclays names Gruber as chemicals head for Europe and Middle East
RE
06/18Banks face overexposure on Evonik unit buyout loan
RE
06/14Gushing European energy IPO pipeline faces muted investor appetite
RE
More sector news : Diversified Chemicals
Chart IMERYS
Duration : Period :
Imerys Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMERYS
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 57,9 €
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Conrad Keijzer Chief Executive Officer & Director
Gilles Michel Chairman
Olivier Pirotte Chief Financial Officer
Aldo Cardoso Independent Director
Ian Gallienne Non-Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IMERYS9.19%4 134
BASF SE2.85%64 932
DUPONT DE NEMOURS INC-30.33%55 195
ROYAL DSM52.16%21 450
SASOL LIMITED-16.63%15 417
GROUPE BRUXELLES LAMBERT12.83%15 318